Abstract
Background The clinical benefit of percutaneous transluminal coronary angioplasty (PTCA) as compared with coronary-artery bypass grafting (CABG) for patients with multivessel coronary artery disease has not been established. To determine the outcomes of these treatments in patients referred for the first time for coronary revascularization, we conducted a three-year prospective, randomized trial comparing the two procedures. Methods Revascularization was performed by accepted methods. Follow-up clinical information was collected every six months, and coronary arteriography and thallium stress scanning were performed at one and three years. The primary end point was a composite of death, Q-wave myocardial infarction, and a large ischemic defect identified on thallium scanning at three years. Secondary end points included clinical and angiographic status and the need for additional revascularization procedures. Data were analyzed according to the intention-to-treat principle. Results Of the 5118 patients sc...
Cite
CITATION STYLE
King, S. B., Lembo, N. J., Weintraub, W. S., Kosinski, A. S., Barnhart, H. X., Kutner, M. H., … Zhao, X.-Q. (1994). A Randomized Trial Comparing Coronary Angioplasty with Coronary Bypass Surgery. New England Journal of Medicine, 331(16), 1044–1050. https://doi.org/10.1056/nejm199410203311602
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.